The use of benzodiazepines and the mental health of women in prison : a cross‑sectional study
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFRGS |
Texto Completo: | http://hdl.handle.net/10183/262532 |
Resumo: | In this article we assessed the prevalence of benzodiazepine (BZD) use in women before and during imprisonment, as well as its related factors and association with symptoms of anxiety, depression, and posttraumatic stress disorder in a quantitative, cross-sectional, analytical study of regional scope. Two female prisons in the Brazilian Prison System were included. Seventy-four women participated by completing questionnaires about their sociodemographic data, BZD use and use of other substances. These questionnaires included the Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-9 (PHQ-9), and Posttraumatic Stress Disorder Checklist–Civilian Version (PCL-C). Of the 46 women who reported no BZDs use before arrest, 29 (63%) began using BZDs during imprisonment (p < 0.001). Positive scores for PTSD, anxiety, and depression, as well as associations between BZD use during imprisonment and anxiety (p= 0.028), depression (p = 0.001) and comorbid anxiety and depression (p= 0.003) were found when a bivariate Poisson regression was performed. When a multivariate Poisson regression was performed for tobacco use, the PHQ-9 and GAD-7 scales, BZD use was associated with depression (p= p = 0.008), with tobacco use (p = 0.012), but not with anxiety (p = 0.325). Imprisonment increases the psychological sufering of women, consequently increasing BZD use. Nonpharmacological measures need to be considered in the health care of incarcerated women. |
id |
UFRGS-2_9545f862435fef91708b474ed962544f |
---|---|
oai_identifier_str |
oai:www.lume.ufrgs.br:10183/262532 |
network_acronym_str |
UFRGS-2 |
network_name_str |
Repositório Institucional da UFRGS |
repository_id_str |
|
spelling |
Einloft, Fernanda Miranda SeixasKopittke, LucianeDias, Míriam Thaís GuterresSchultz, Águida Luana VeriatoDotta-Panichi, Renata MariaBarros, Helena Maria Tannhauser2023-07-21T03:30:42Z20232045-2322http://hdl.handle.net/10183/262532001170696In this article we assessed the prevalence of benzodiazepine (BZD) use in women before and during imprisonment, as well as its related factors and association with symptoms of anxiety, depression, and posttraumatic stress disorder in a quantitative, cross-sectional, analytical study of regional scope. Two female prisons in the Brazilian Prison System were included. Seventy-four women participated by completing questionnaires about their sociodemographic data, BZD use and use of other substances. These questionnaires included the Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-9 (PHQ-9), and Posttraumatic Stress Disorder Checklist–Civilian Version (PCL-C). Of the 46 women who reported no BZDs use before arrest, 29 (63%) began using BZDs during imprisonment (p < 0.001). Positive scores for PTSD, anxiety, and depression, as well as associations between BZD use during imprisonment and anxiety (p= 0.028), depression (p = 0.001) and comorbid anxiety and depression (p= 0.003) were found when a bivariate Poisson regression was performed. When a multivariate Poisson regression was performed for tobacco use, the PHQ-9 and GAD-7 scales, BZD use was associated with depression (p= p = 0.008), with tobacco use (p = 0.012), but not with anxiety (p = 0.325). Imprisonment increases the psychological sufering of women, consequently increasing BZD use. Nonpharmacological measures need to be considered in the health care of incarcerated women.application/pdfengScientific reports. London. Vol. 13 (2023), 4491, p. 1-9MulheresPrisõesBenzodiazepinasSaúde mentalThe use of benzodiazepines and the mental health of women in prison : a cross‑sectional studyEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001170696.pdf.txt001170696.pdf.txtExtracted Texttext/plain43437http://www.lume.ufrgs.br/bitstream/10183/262532/2/001170696.pdf.txt55533e6492d04db2cb6d9265f8798129MD52ORIGINAL001170696.pdfTexto completo (inglês)application/pdf1250264http://www.lume.ufrgs.br/bitstream/10183/262532/1/001170696.pdf745ba5a07c9e2d895ad3c66d1547c498MD5110183/2625322023-07-22 03:41:24.505379oai:www.lume.ufrgs.br:10183/262532Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2023-07-22T06:41:24Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.pt_BR.fl_str_mv |
The use of benzodiazepines and the mental health of women in prison : a cross‑sectional study |
title |
The use of benzodiazepines and the mental health of women in prison : a cross‑sectional study |
spellingShingle |
The use of benzodiazepines and the mental health of women in prison : a cross‑sectional study Einloft, Fernanda Miranda Seixas Mulheres Prisões Benzodiazepinas Saúde mental |
title_short |
The use of benzodiazepines and the mental health of women in prison : a cross‑sectional study |
title_full |
The use of benzodiazepines and the mental health of women in prison : a cross‑sectional study |
title_fullStr |
The use of benzodiazepines and the mental health of women in prison : a cross‑sectional study |
title_full_unstemmed |
The use of benzodiazepines and the mental health of women in prison : a cross‑sectional study |
title_sort |
The use of benzodiazepines and the mental health of women in prison : a cross‑sectional study |
author |
Einloft, Fernanda Miranda Seixas |
author_facet |
Einloft, Fernanda Miranda Seixas Kopittke, Luciane Dias, Míriam Thaís Guterres Schultz, Águida Luana Veriato Dotta-Panichi, Renata Maria Barros, Helena Maria Tannhauser |
author_role |
author |
author2 |
Kopittke, Luciane Dias, Míriam Thaís Guterres Schultz, Águida Luana Veriato Dotta-Panichi, Renata Maria Barros, Helena Maria Tannhauser |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Einloft, Fernanda Miranda Seixas Kopittke, Luciane Dias, Míriam Thaís Guterres Schultz, Águida Luana Veriato Dotta-Panichi, Renata Maria Barros, Helena Maria Tannhauser |
dc.subject.por.fl_str_mv |
Mulheres Prisões Benzodiazepinas Saúde mental |
topic |
Mulheres Prisões Benzodiazepinas Saúde mental |
description |
In this article we assessed the prevalence of benzodiazepine (BZD) use in women before and during imprisonment, as well as its related factors and association with symptoms of anxiety, depression, and posttraumatic stress disorder in a quantitative, cross-sectional, analytical study of regional scope. Two female prisons in the Brazilian Prison System were included. Seventy-four women participated by completing questionnaires about their sociodemographic data, BZD use and use of other substances. These questionnaires included the Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-9 (PHQ-9), and Posttraumatic Stress Disorder Checklist–Civilian Version (PCL-C). Of the 46 women who reported no BZDs use before arrest, 29 (63%) began using BZDs during imprisonment (p < 0.001). Positive scores for PTSD, anxiety, and depression, as well as associations between BZD use during imprisonment and anxiety (p= 0.028), depression (p = 0.001) and comorbid anxiety and depression (p= 0.003) were found when a bivariate Poisson regression was performed. When a multivariate Poisson regression was performed for tobacco use, the PHQ-9 and GAD-7 scales, BZD use was associated with depression (p= p = 0.008), with tobacco use (p = 0.012), but not with anxiety (p = 0.325). Imprisonment increases the psychological sufering of women, consequently increasing BZD use. Nonpharmacological measures need to be considered in the health care of incarcerated women. |
publishDate |
2023 |
dc.date.accessioned.fl_str_mv |
2023-07-21T03:30:42Z |
dc.date.issued.fl_str_mv |
2023 |
dc.type.driver.fl_str_mv |
Estrangeiro info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10183/262532 |
dc.identifier.issn.pt_BR.fl_str_mv |
2045-2322 |
dc.identifier.nrb.pt_BR.fl_str_mv |
001170696 |
identifier_str_mv |
2045-2322 001170696 |
url |
http://hdl.handle.net/10183/262532 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.pt_BR.fl_str_mv |
Scientific reports. London. Vol. 13 (2023), 4491, p. 1-9 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFRGS instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Repositório Institucional da UFRGS |
collection |
Repositório Institucional da UFRGS |
bitstream.url.fl_str_mv |
http://www.lume.ufrgs.br/bitstream/10183/262532/2/001170696.pdf.txt http://www.lume.ufrgs.br/bitstream/10183/262532/1/001170696.pdf |
bitstream.checksum.fl_str_mv |
55533e6492d04db2cb6d9265f8798129 745ba5a07c9e2d895ad3c66d1547c498 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
|
_version_ |
1815447832716378112 |